Demo Sign up Log In

Novo Nordisk A/S Common Stock (NVO)

R&D Expenses

kr 17.79B

Quarterly · Period ending: Jun 30, 2026 · DKK

NVO R&D Expenses

Latest reportedkr 17.79B DKKperiod endingJun 30, 2026

Latest reportedkr 17.79B DKKperiod endingJun 30, 2026

NVO Quarterly R&D Expenses · DKK (kr 0.00 → kr 17.79B)

Quarterly R&D Expenses

High-resolution chart · PNG

NVO r&d expenses history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock R&D Expenses — Quarterly (DKK)
Period ending	R&D Expenses (DKK)
Jun 30, 2001	0
Mar 31, 2001	0
Dec 31, 2000	0
Sep 30, 2000	0
Jun 30, 2000	0
Mar 31, 2000	0
Dec 31, 1999	0
Sep 30, 1999	0
Jun 30, 1999	0
Mar 31, 1999	0
Dec 31, 1998	0
Sep 30, 1998	0
Jun 30, 1998	0
Mar 31, 1998	0
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	0
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Dec 31, 1987	0
Sep 30, 1987	0
Jun 30, 1987	0
Mar 31, 1987	0
Dec 31, 1986	0
Sep 30, 1986	0
Jun 30, 1986	0
Mar 31, 1986	0
Dec 31, 1985	0
Sep 30, 1985	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.